immatics biotechnologies GmbH
Utility Patent Applications

Last updated:

List of all immatics biotechnologies GmbH patents 454 in total

Status Patent
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 8 Aug 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 8 Aug 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 1 Aug 2019
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 9 Sep 2025 Issue date: 1 Aug 2019

Showing 450 to 454 of 454 patents.